Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hologic, Inc. - Common Stock (NQ: HOLX )

63.24 -0.38 (-0.60%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Hologic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
GE HealthCare Earnings: What To Look For From GEHC
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) will be reporting earnings tomorrow morning. Here’s what investors should know. 
Via StockStory
NASDAQ:HOLX is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Uncover the potential of HOLOGIC INC, an undervalued stock. NASDAQ:HOLX maintains a strong financial position and offers an appealing valuation. 
Via Chartmill
QuidelOrtho Earnings: What To Look For From QDEL
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be announcing earnings results tomorrow afternoon. Here’s what to expect. 
Via StockStory
Which S&P500 stocks are moving on Thursday?
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Gapping S&P500 stocks in Thursday's session
Stay updated with the S&P500 gap up and gap down stocks on Thursday. Get a glimpse of the market's movement during today's session. 
Via Chartmill
Hologic Q1 Earnings Assessment
Via Benzinga
Hologic Earnings Report: Q1 Overview
Via Benzinga
Wondering what's happening in today's S&P500 pre-market session?
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
Uber To $80? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Ford, Skyworks Solutions, FormFactor And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Hologic Earnings Review: Q1 Summary
Via Benzinga
Earnings Scheduled For February 5, 2025
Via Benzinga
5 Analysts Have This To Say About Hologic
Via Benzinga
How Is The Market Feeling About Hologic?
Via Benzinga
Peering Into Hologic's Recent Short Interest
Via Benzinga
Hologic (NASDAQ:HOLX) Reports Q4 In Line With Expectations But Full-Year Sales Guidance Misses Expectations
Medical technology company Hologic (NASDAQ:HOLX) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $1.02 billion. On the other hand, next quarter’s revenue... 
Via StockStory
Friday's pre-market session: top gainers and losers in the S&P500 index
Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session. 
Via Chartmill
5 S&P 500 Stocks Set To Shine In The Final Week Of January — If History Repeats Itself
S&P 500 surges to record highs in final week of January as investors react to economic optimism, Trump's leadership, and AI investments. 
Via Benzinga
Topics Artificial Intelligence Government Stocks
Exposures Artificial Intelligence Political US Equities
FDA Warns Hologic Over BioZorb Manufacturing Violations
FDA issues warning to Hologic, citing manufacturing and safety violations for BioZorb devices. Patient safety risks and reporting failures highlighted 
Via Benzinga
Exposures Product Safety
Expert Ratings For Hologic
Via Benzinga
Peering Into Hologic's Recent Short Interest
Via Benzinga
Looking Into Hologic's Recent Short Interest
Via Benzinga
This James Hardie Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday. 
Via Benzinga
Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints
FDA and Hologic advise health providers to return all unused BioZorb Markers due to adverse events, including pain and infection. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments
Hologic Inc. is acquiring Gynesonics for $350 million, adding the Sonata System to its fibroid treatment lineup. The acquisition aims to boost Hologic's women's health offerings and expand minimally... 
Via Benzinga
Assessing Hologic: Insights From 10 Financial Analysts
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,600 Today
Via Benzinga
Critical Insights From Hologic Analyst Ratings: What You Need To Know
Via Benzinga
Here's How Much You Would Have Made Owning Hologic Stock In The Last 20 Years
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.